Nycomed wins EU approval for COPD therapy - FierceBiotech
Links shared publicly online about this topic.
- 1,042total visits
Nycomed wins EU approval for COPD therapy - FierceBiotech
Despite being rebuffed by the FDA and its drug experts, Switzerland's Nycomed has won EU approval for Daxas, its new therapy to treat chronic obstructive pulmonary disorder. The approval will usher... Read more...
View full resource at fiercebiotech.com
Tags: COPD, Disease and Condition, Drug, Pharma, Biotech, FDA, Nycomed, Pulmonology
Most Recently Shared on July 6, 2010 at 3:31 pm By:
RT @BiotechNews Nycomed wins EU approval for COPD therapy: Despite being rebuffed by the FDA... http://bit.ly/aFXFNj #Pharma #BioTech
UPDATE 2-EU agency backs Nycomed's Daxas after U.S. rebuff | Reuters
reuters.com — “* European Medicines Agency recommends Daxas for COPD * Decision follows vote against approval by U.S. panel * Forest Laboratories has U.S. rights to Daxas (Adds comment from Nycomed, details on” View full resource at reuters.com
Most Recently Shared on April 23, 2010 at 11:32 am By:
Ben Hirschler Health Communicator
Lose some...win some: Nycomed's COPD drug Daxas gets EU green light after US rebuff http://www.reuters.com/article/idUSLDE63M10W20100423
Advertisement
